Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

PFE

Pfizer Inc

Dec 22 • 04:00PM ET

25.21

+0.02 0.08 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Index	S&P 500	P/E	14.69	EPS (ttm)	1.72	Insider Own	0.09%	Shs Outstand	5.69B	Perf Week	-4.62%
Market Cap	143.34B	Forward P/E	8.41	EPS next Y	3.00	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	3.32%
Enterprise Value	190.36B	PEG	-	EPS next Q	0.59	Inst Own	66.89%	Short Float	2.45%	Perf Quarter	4.48%
Income	9.80B	P/S	2.28	EPS this Y	0.17%	Inst Trans	-0.27%	Short Ratio	2.02	Perf Half Y	3.70%
Sales	62.78B	P/B	1.54	EPS next Y	-3.77%	ROA	4.58%	Short Interest	139.07M	Perf YTD	-4.98%
Book/sh	16.32	P/C	9.57	EPS next 5Y	-2.50%	ROE	10.59%	52W High	27.69 -8.96%	Perf Year	-2.63%
Cash/sh	2.64	P/FCF	13.81	EPS past 3/5Y	-28.69% -13.27%	ROIC	6.52%	52W Low	20.92 20.54%	Perf 3Y	-52.98%
Dividend Est.	1.70 (6.75%)	EV/EBITDA	7.28	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	69.12%	Volatility	2.48% 2.18%	Perf 5Y	-34.87%
Dividend TTM	1.72 (6.82%)	EV/Sales	3.03	EPS Y/Y TTM	128.96%	Oper. Margin	30.99%	ATR (14)	0.58	Perf 10Y	-17.34%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.97	Sales Y/Y TTM	4.44%	Profit Margin	15.60%	RSI (14)	47.78	Recom	2.39
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.28	EPS Q/Q	-20.96%	SMA20	-1.35%	Beta	0.43	Target Price	28.51
Payout	120.11%	Debt/Eq	0.66	Sales Q/Q	-5.92%	SMA50	0.52%	Rel Volume	0.55	Prev Close	25.19
Employees	81000	LT Debt/Eq	0.62	Earnings	Nov 04 BMO	SMA200	2.84%	Avg Volume	68.84M	Price	25.21
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	37.53% 0.94%	Trades		Volume	38,758,872	Change	0.08%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47

Show Previous Ratings

Dec-22-25 01:43PM	Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends (Zacks)
08:19AM	This Pharma Stock Had a Rough Year. Why One Analyst Thinks It Can Rise 250%. (Barrons.com)
03:58AM	Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead? (Motley Fool)
Dec-21-25 10:07AM	Jim Cramer on Pfizer: "I'm Going to Say Just Weak Hold" (Insider Monkey)
Dec-20-25 07:00AM	MarketBeat Week in Review - 12/15 - 12/19 (MarketBeat)
05:40PM	Loading…
Dec-19-25 05:40PM	Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump (Investor's Business Daily)
04:30PM	Nine Drugmakers Strike Deals With Trump, With More to Come (Bloomberg)
04:07PM	Lilly Shares Have Tripled on Weight-Loss Drugs. Why the Stock Looks Cheap. (Barrons.com)
03:20PM	Better Buy in 2026: Pfizer or Merck? (Motley Fool)
03:14PM	White House Cuts Drug-Pricing Deals With Pharma Companies, Tilting System Toward Self-Pay (Barrons.com)
12:15PM	Pharma's $370B Bet on America: The ETF Plays for 2026 (Zacks)
11:42AM	White House Will Announce Pricing Deals With More Drugmakers Friday (Barrons.com)
10:46AM	Pfizer Down After It Issues Muted 2026 Outlook: How to Play the Stock (Zacks)
09:51AM	Pfizer (PFE) CEO's Struggling Because Of "a Good Hand," Says Jim Cramer (Insider Monkey)
06:01AM	Novo files for CagriSema approval; Merck and Pfizers trial win (BioPharma Dive)
08:50PM	Loading…
Dec-18-25 08:50PM	3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now (Motley Fool)
12:05PM	Better Buy in 2026: Pfizer or Eli Lilly? (Motley Fool)
10:40AM	3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment (Zacks)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts (Business Wire)
05:30AM	JPMorgan Quants Warn of Extreme Crowding in Speculative Stocks (Bloomberg)
Dec-17-25 08:09PM	Lightning Round: I would buy M&T Bank tomorrow morning, says Jim Cramer (CNBC TV)
05:08PM	Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress (Insider Monkey)
12:07PM	If I Could Only Buy and Hold a Single Stock, This Would Be It (Motley Fool)
11:26AM	CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy? (Zacks)
09:59AM	Pfizer Issues Soft 2026 View: What Does It Mean for the Stock's Future? (Zacks)
09:51AM	Company News for Dec 17, 2025 (Zacks)
08:35AM	The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now (Motley Fool)
06:45AM	PADCEV Plus Keytruda Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility (PR Newswire)
06:19AM	S&P Futures Gain as Investors Weigh U.S. Jobs Data, Fed Speak and Micron Earnings in Focus (Barchart)
Dec-16-25 05:50PM	Analyst Report: Pfizer Inc. (Morningstar Research)
05:45PM	Loading…
05:45PM	Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
04:33PM	Stocks Settle Mixed on Soft US Economic News (Barchart)
04:24PM	Stock Market Today: Dow Slides, Nasdaq Positive After Jobs Data; Nvidia Rises (Live Coverage) (Investor's Business Daily)
04:22PM	Why Pfizer's 2026 Guidance Miss Is 'Not A Major Surprise' (Investor's Business Daily)
04:21PM	Monte Rosa Scores A Win In Prostate Cancer, And Rockets To A Four-Year High (Investor's Business Daily)
04:18PM	These Stocks Moved the Most Today: Tesla, Pfizer, Humana, Circle, CoreWeave, Broadcom, IonQ, Ford, Navan, and More (Barrons.com)
04:03PM	Tepid 2026 outlook dents Pfizer shares (AFP)
03:37PM	Pfizer outlook, Humana leadership shake-up, Kraft Heinz's new CEO (Yahoo Finance Video)
02:14PM	These Stocks Are Moving the Most Today: Tesla, Pfizer, Humana, Circle, CoreWeave, Broadcom, IonQ, Ford, Navan, and More (Barrons.com)
02:08PM	Stock Market Today: Dow Drops After Mixed Jobs Data; Cannabis Stocks Soar (Live Coverage) (Investor's Business Daily)
01:39PM	Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures (Pharmaceutical Technology)
01:08PM	Energy and healthcare stocks are dragging the market lower on Tuesday (MarketWatch)
01:04PM	Pfizer falls on disappointing guidance (CNBC TV)
12:07PM	Pfizer CEO Defends Vaccines, Promises Growth by End of Decade (Barrons.com)
11:36AM	Why Pfizer (PFE) Stock Is Sliding Today (GuruFocus.com)
11:10AM	Pfizer Sees 2026 Profit Below Estimates as COVID Sales Decline (GuruFocus.com)
09:40AM	Kraft Heinz taps new CEO, PayPal files for US bank charter (Yahoo Finance Video)
07:47AM	Here's why Pfizer is revising its revenue forecasts (MarketWatch)
07:25AM	Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales. (Barrons.com)
07:16AM	Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings (The Wall Street Journal)
07:03AM	Pfizer Adds to Its Big Bet on Weight Loss Drugs (MarketBeat)
06:45AM	Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance (Business Wire)
05:35AM	Where Will Eli Lilly Be in 10 Years? (Motley Fool)
Dec-15-25 09:32AM	BMY Gains 13.1% in Three Months: Buy, Sell or Hold the Stock? (Zacks)
09:00AM	Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know (Zacks)
09:00AM	GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients (NewMediaWire)
Dec-14-25 03:47PM	Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? (Motley Fool)
Dec-13-25 07:13AM	Forget Teladoc and Buy This Healthcare Stock Instead (Motley Fool)
Dec-12-25 12:00PM	Pfizer Declares First-Quarter 2026 Dividend (Business Wire)
11:52AM	Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. (Motley Fool)
11:17AM	Eli Lilly's Next-Generation Obesity Drug Secures First Phase III Win (Zacks)
10:35AM	The Best Turnaround Stock to Invest $1,000 in Right Now (Motley Fool)
Dec-11-25 02:03PM	Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.? (GuruFocus.com)
10:57AM	CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock? (Zacks)
10:09AM	Pfizer plans job cuts in Switzerland to reduce expenses (Pharmaceutical Technology)
07:49AM	Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth (Zacks)
07:32AM	Pfizer Inc. (PFE) Announces Results from Phase 3 BASIS Study (Insider Monkey)
03:45AM	Ex-Pfizer executive joins Elevances board as insurer pursues pharmacy experience (Healthcare Dive)
Dec-10-25 05:45PM	Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider (Zacks)
04:35PM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
11:47AM	This Invesco ETF Pays a 4.71% Yield With 50 Low-Volatility Dividend Stocks (3x the S&P 500) (24/7 Wall St.)
11:28AM	Pfizer Inc. (PFE) Announces Results from the Phase 3 BASIS Study Evaluating HYMPAVZI (Insider Monkey)
08:15AM	TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer (Business Wire)
07:43AM	PFE Buys Oral GLP-1 Drug From China Biotech to Boost Obesity Presence (Zacks)
07:31AM	JNJ vs. PFE: Which Blue-Chip Drug Stock is the Better Investment Now? (Zacks)
06:26AM	The Fed's Divided on Rates. Why Stock Markets Can Rise Through 2026 Anyway and 5 Other Things to Know Today. (Barrons.com)
04:30AM	China's Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer (South China Morning Post)
Dec-09-25 04:35PM	Down 50%, Should You Buy the Dip on Pfizer? (Motley Fool)
04:13PM	In The 'Uber Bull' Biotech Market, Is Structure The Next Metsera? (Investor's Business Daily)
01:40PM	Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal (Zacks)
12:30PM	Pfizer Expands Obesity Pipeline With Up to $2.1 Billion Deal for YaoPharma Pill (GuruFocus.com)
11:50AM	Pfizer Turns to China for Trial Weight Loss Drug. Congress Is Worried About Chinese Biotechs. (Barrons.com)
09:26AM	Pfizer gains another obesity asset with $2bn deal for YaoPharmas GLP-1RA (Pharmaceutical Technology)
06:30AM	Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma (Business Wire)
05:59AM	Pfizer dips into China for another try at an obesity pill (BioPharma Dive)
Dec-08-25 12:00PM	Drugmakers Are Ditching Middlemen to Sell Directly to Patients (The Wall Street Journal)
Dec-06-25 05:15PM	HYMPAVZI (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors (Business Wire)
09:52AM	Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue (24/7 Wall St.)
Dec-05-25 04:25PM	Do These 3 Healthcare Stocks Need a Checkup? (Motley Fool)
10:25AM	2 Headwinds Facing Pfizer Stock Going Into 2026 (Motley Fool)
10:24AM	3 Low-Volatility Stocks with Warning Signs (StockStory)
09:23AM	Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead? (Zacks)
Dec-04-25 11:02PM	3 Reasons PFE is Risky and 1 Stock to Buy Instead (StockStory)
09:48PM	Pfizer Inc. (PFE): A Bull Case Theory (Insider Monkey)
11:30AM	Pfizer (PFE) Up 3.9% Since Last Earnings Report: Can It Continue? (Zacks)
12:05AM	Jim Cramer on Pfizer: "I Would Hold on to It" (Insider Monkey)
Dec-02-25 12:28PM	LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website (Zacks)
12:11PM	17 dividend-stock bargains from a value manager with a stellar track record (MarketWatch)
10:24AM	Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure (Zacks)
09:40AM	Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM

Open in Screener

KMX

Carmax Inc

Dec 22 • 04:00PM ET

38.15

-0.32 -0.83 %

Consumer Cyclical • Auto & Truck Dealerships • USA • NYSE

Peers: AN LAD PAG SAH ABG GPI TSLA GM F HOG

| Held by: IJR VTI VB VBR VXF IJS SPSM SLYV RWJ IWR

Index	-	P/E	12.62	EPS (ttm)	3.02	Insider Own	0.53%	Shs Outstand	146.84M	Perf Week	-6.77%
Market Cap	5.60B	Forward P/E	14.81	EPS next Y	2.58	Insider Trans	1.47%	Shs Float	146.06M	Perf Month	13.81%
Enterprise Value	22.68B	PEG	-	EPS next Q	0.18	Inst Own	102.14%	Short Float	10.36%	Perf Quarter	-33.77%
Income	457.84M	P/S	0.20	EPS this Y	-16.29%	Inst Trans	-4.83%	Short Ratio	2.55	Perf Half Y	-44.88%
Sales	27.38B	P/B	0.90	EPS next Y	-4.17%	ROA	1.73%	Short Interest	15.13M	Perf YTD	-53.34%
Book/sh	42.39	P/C	7.25	EPS next 5Y	-	ROE	7.46%	52W High	89.47 -57.36%	Perf Year	-53.14%
Cash/sh	5.26	P/FCF	2.87	EPS past 3/5Y	-22.80% -9.64%	ROIC	1.98%	52W Low	30.26 26.07%	Perf 3Y	-41.66%
Dividend Est.	-	EV/EBITDA	28.65	Sales past 3/5Y	-5.28% 5.66%	Gross Margin	10.98%	Volatility	4.62% 3.93%	Perf 5Y	-60.31%
Dividend TTM	-	EV/Sales	0.83	EPS Y/Y TTM	2.78%	Oper. Margin	1.71%	ATR (14)	1.62	Perf 10Y	-34.06%
Dividend Ex-Date	-	Quick Ratio	0.51	Sales Y/Y TTM	-1.49%	Profit Margin	1.67%	RSI (14)	44.44	Recom	3.09
Dividend Gr. 3/5Y	- -	Current Ratio	1.99	EPS Q/Q	-47.21%	SMA20	-2.77%	Beta	1.29	Target Price	34.20
Payout	0.00%	Debt/Eq	2.94	Sales Q/Q	-13.43%	SMA50	-2.86%	Rel Volume	1.20	Prev Close	38.47
Employees	30048	LT Debt/Eq	2.81	Earnings	Dec 18 BMO	SMA200	-33.56%	Avg Volume	5.93M	Price	38.15
IPO	Feb 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.34% 2.71%	Trades		Volume	7,109,200	Change	-0.83%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-12-25	Initiated	Barclays	Underweight	$28
Nov-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$35
Nov-07-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-07-25	Downgrade	Needham	Buy → Hold
Nov-06-25	Downgrade	William Blair	Outperform → Mkt Perform
Nov-06-25	Downgrade	The Benchmark Company	Buy → Hold
Nov-06-25	Downgrade	JP Morgan	Neutral → Underweight	$30
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80
May-19-25	Resumed	Wedbush	Outperform	$90
Mar-26-25	Upgrade	Stephens	Equal-Weight → Overweight	$86 → $90
Feb-06-25	Upgrade	Evercore ISI	In-line → Outperform	$90 → $110
Dec-05-24	Initiated	Stephens	Equal-Weight	$86
Mar-20-24	Upgrade	Needham	Hold → Buy	$99

Show Previous Ratings

Dec-22-25 08:59AM	Bear of the Day: CarMax (KMX) (Zacks)
03:34AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-20-25 10:00AM	3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500 (MarketBeat)
Dec-19-25 07:38AM	CarMax Q3 Earnings Surpass Expectations, Revenues Decline Y/Y (Zacks)
12:30AM	KMX Q4 Deep Dive: Margin Reset and Leadership Transition Dominate CarMax's Strategy (StockStory)
04:18PM	Loading…
Dec-18-25 04:18PM	Stocks to Watch Thursday: Trump Media, Micron, Lululemon, Accenture (The Wall Street Journal)
04:01PM	CarMax Inc (KMX) Q3 2026 Earnings Call Highlights: Navigating Sales Decline and Strategic ... (GuruFocus.com)
12:57PM	CarMax Cutting Prices to Draw Car Shoppers Back (The Wall Street Journal)
12:36PM	CarMax Crashes into a Sales Slump as Amazon Circles the Used-Car Lot (GuruFocus.com)
11:53AM	These Stocks Are Moving the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More (Barrons.com)
10:49AM	CarMax Scores an Earnings Beat. The Stock Barely Moves. (Barrons.com)
10:46AM	Stock Market Today: Indexes Rise; Nvidia, Tesla Rally But Some Electronics Firms Struggle (Live Coverage) (Investor's Business Daily)
10:15AM	Stock Market Today: Dow, Small Caps Rise On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:37AM	Stock Market Today: Dow Rises On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:30AM	CarMax (KMX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:00AM	Loading…
08:00AM	CarMax (KMX) Q3 Earnings and Revenues Top Estimates (Zacks)
07:40AM	CarMax flags lower margins, higher marketing spend; shares slide (Investing.com)
07:18AM	CarMax Beats Earnings Expectations. Why the Stock Is Falling. (Barrons.com)
07:16AM	CarMax Profit Sinks as Struggles Continue (The Wall Street Journal)
07:13AM	CarMax (NYSE:KMX) Beats Q4 CY2025 Sales Expectations (StockStory)
07:00AM	CarMax: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:50AM	CarMax Reports Third Quarter Fiscal Year 2026 Results (Business Wire)
05:33AM	Nike headlines Thursday's earnings slate (MarketWatch)
04:24AM	Stock Market Today: S&P 500 and Dow strive to break 4-day losing streak, Nasdaq called higher as Micron results lift tech sentiment; CPI inflation data due; Nike earnings on tap. (MarketWatch)
03:26AM	FedEx, Nike Earnings; Inflation Report: Still to Come This Week (The Wall Street Journal)
Dec-17-25 07:00PM	November CPI, Nike earnings, mortgage rates: What to Watch (Yahoo Finance Video)
Dec-16-25 10:34PM	Spotting Winners: CarMax (NYSE:KMX) And Vehicle Retailer Stocks In Q3 (StockStory)
10:01PM	CarMax Earnings: What To Look For From KMX (StockStory)
Dec-15-25 12:48PM	Reddit Investors Have No Faith in Used Car Stocks \| CVNA CARS CARG (24/7 Wall St.)
11:20AM	Tesla Owner Regrets Thinking His EV Was An 'Investment'Says He's 'Genuinely Shocked At How Much These Things Are Tanking' After Losing $750 A Month (Benzinga)
09:15AM	Loading…
09:15AM	Stay Ahead of the Game With CarMax (KMX) Q3 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Dec-14-25 07:31AM	Trump's Fed pick comes into focus, economic data backlog clears: What to watch this week (Yahoo Finance)
05:00AM	What to Expect in Markets This Week: Jobs Report, Inflation Data, Earnings From Micron, Nike and FedEx (Investopedia)
Dec-11-25 12:29PM	Carvana Stock Is Joining the S&P 500. Should You Buy Shares Now? (Barchart)
10:00AM	Earnings Preview: CarMax (KMX) Q3 Earnings Expected to Decline (Zacks)
09:15AM	Vera Bradley (VRA) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
08:38AM	The Week Ahead: Nike, Micron Put a Bow on 2025 Earnings (Schaeffer's Research)
07:50AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-09-25 11:59AM	CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman (PR Newswire)
09:00AM	CarMax, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - KMX (PR Newswire)
08:05AM	AutoZone (AZO) Q1 Earnings and Revenues Miss Estimates (Zacks)
Dec-08-25 02:39PM	Carvana Stock Heads for a New High. There's More to the Story Than S&P 500 Inclusion. (Barrons.com)
12:16PM	Carvana Stock Heads for Record Closing High. There's More to Story Than S&P 500 Inclusion. (Barrons.com)
11:30AM	Carvana stock surges on S&P 500 inclusion, marking dramatic turnaround (Yahoo Finance)
08:31AM	Here's What Affected CarMax (KMX) in Q3 (Insider Monkey)
03:15AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-05-25 08:56AM	Wedbush Says Its Time to Take Advantage and Buy the Dip in This 1 Former Meme Stock (Barchart)
Dec-04-25 08:00AM	The Week Ahead: Nike, Micron Put a Bow on 2025 Earnings (Schaeffer's Research)
Dec-03-25 02:56PM	CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman (PR Newswire)
Dec-02-25 01:16PM	The Real Price of Passive: Its Not the Expense Ratio (etf.com)
Dec-01-25 03:18PM	KMX SHAREHOLDERS: CarMax, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by January 2 (Newsfile)
Nov-30-25 02:15AM	What Every CarMax Investor Should Know Before Buying (Motley Fool)
Nov-29-25 10:48AM	Has KMX Stock Been Good for Investors? (Motley Fool)
Nov-28-25 05:55PM	CarMax, Inc. (KMX) Investor Lawsuit Filed, Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline -- Hagens Berman (PR Newswire)
07:48AM	Is CarMax (KMX) Facing Cyclical Weakness? (Insider Monkey)
Nov-25-25 05:00PM	Carmax Announces Third Quarter Conference Call (Business Wire) +5.33%
08:45AM	Investors in CarMax, Inc. Should Contact Levi & Korsinsky Before January 2, 2026 to Discuss Your Rights - KMX (PR Newswire)
Nov-24-25 02:54PM	Carvana Stock Is Rising. Ignore the Struggling Car Market, Say Analysts. (Barrons.com)
01:27PM	Is Carvana the 'New Used Car King?' These Analysts Think So, and the Stock Is Rising. (Investopedia)
12:30PM	Wedbush Lifts Carvana With $400 Target And 30% Upside (GuruFocus.com)
12:06PM	Carvana Stock Jumps. Ignore the Struggling Car Market, Say Analysts. (Barrons.com)
11:14AM	The Auto Market Is in Rough Shape. Buy Carvana Stock Anyway, Analyst Says. (Barrons.com)
02:41AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Nov-21-25 05:50PM	CarMax and Lithia Stocks Trade Up, What You Need To Know (StockStory) +5.40%
Nov-20-25 10:35AM	CarMax Opens First Arkansas Store in Rogers, Expanding to 42 States Nationwide (GlobeNewswire)
Nov-18-25 02:15PM	Why CarMax (KMX) Stock Is Up Today (StockStory)
09:00AM	CarMax Rolls Out Nationwide At-Home Pickup- Sell Your Car Without Leaving Your Driveway (GlobeNewswire)
Nov-17-25 11:34PM	3 Profitable Stocks We Steer Clear Of (StockStory) -6.74%
04:34PM	Amazon, Ford Partner on Used Cars. 4 Stocks That Could Be Impacted. (Barrons.com)
09:41AM	Carvana and CarMax stock falls after Ford partners with Amazon (Investing.com)
09:37AM	Ford Taps Amazon to Let Shoppers Buy Its Used Cars Online (Bloomberg)
09:00AM	Paige Bueckers and Donovan Mitchell Take the Wheel in CarMax's "Wanna Drive?" Campaign (GlobeNewswire)
Nov-16-25 10:03AM	Poorly Run CarMax (KMX) "Misjudged" The Market, Says Jim Cramer (Insider Monkey)
12:12AM	Jim Cramer on CarMax: "I Would Not Own That Stock" (Insider Monkey)
Nov-13-25 08:43PM	Lightning Round: ServiceNow's fundamentals are very good, says Jim Cramer (CNBC TV)
Nov-12-25 12:12PM	Is Carvana (CVNA) Actually In Trouble? (24/7 Wall St.)
09:45AM	Carvana initiated, AT upgraded: Wall Street's top analyst calls (The Fly)
02:49AM	CarMax Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
Nov-11-25 12:26PM	Why CarMax (KMX) Stock Is Trading Up Today (StockStory)
12:11PM	CarMax is 'stuck in neutral.' And yes, it's also about Carvana. (MarketWatch)
09:40AM	Shareholders of CarMax, Inc. (KMX): Protect Your Rights Before January 2, 2026 - Contact Levi & Korsinsky (Newsfile)
09:18AM	Shareholders who lost money in shares of CarMax, Inc. (NASDAQ: KMX) Should Contact Wolf Haldenstein Immediately (PR Newswire)
08:45AM	CarMax, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 2, 2026 to Discuss Your Rights - KMX (PR Newswire)
04:13AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Nov-10-25 11:34AM	CarMax downgraded by Morgan Stanley amid execution woes and leadership uncertainty (Investing.com)
09:39AM	Coinbase upgraded, Six Flags downgraded: Wall Street's top analyst calls (The Fly)
09:11AM	Here Are Mondays Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More (24/7 Wall St.)
Nov-07-25 09:33AM	Datadog, Trade Desk upgraded: Wall Street's top analyst calls (The Fly)
Nov-06-25 11:55PM	CarMax rings alarm on used car market, drags Carvana down (TheStreet) -24.33%
07:46PM	Here Are Fridays Top Wall Street Analyst Research Calls: Advanced Micro Devices, Baidu, Datadog, Expedia, Unity Software and More (24/7 Wall St.)
04:26PM	These Stocks Moved the Most Today: Duolingo, Marvell, Tesla, Qualcomm, Robinhood, CarMax, Datadog, DoorDash, and More (Barrons.com)
04:25PM	How major US stock indexes fared Thursday, 11/6/2025 (Associated Press Finance)
04:11PM	CarMax CEO abruptly steps down, Peloton recalls 800K+ bikes (Yahoo Finance Video)
03:04PM	Analyst Report: CarMax, Inc. (Morningstar Research)
02:52PM	These Stocks Are Moving the Most Today: Duolingo, Marvell, Tesla, Qualcomm, Robinhood, CarMax, Datadog, DoorDash, and More (Barrons.com)
11:10AM	CarMax Cuts Ties With CEO, Expects Weak Third Quarter (The Wall Street Journal)
11:09AM	Stock Market Today: U.S. Stocks Soldier Higher Despite Largest October Job Cuts In 22 Years (TheStreet)
09:46AM	CarMax Sacks CEO and Slashes Outlook (The Wall Street Journal)
09:45AM	Caterpillar upgraded, Elf Beauty downgraded: Wall Street's top analyst calls (The Fly)
08:51AM	CarMax Stock Plunges on CEO Change. What's Behind the Surprise. (Barrons.com)

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ONeil Mark F	Director	Oct 02 '25	Buy	46.21	10,816	499,807	24,690	Oct 06 04:11 PM
STEENROD MITCHELL D	Director	Oct 02 '25	Buy	45.57	2,000	91,140	38,330	Oct 03 04:09 PM
Daniels Jon G	EVP, CAF	Jul 02 '25	Sale	70.64	1,540	108,786	2,779	Jul 03 04:11 PM
JON DANIELS	Officer	Jul 02 '25	Proposed Sale	70.64	1,540	108,790		Jul 02 04:27 PM
STEENROD MITCHELL D	Director	Apr 24 '25	Buy	65.49	1,300	85,137	33,577	Apr 25 04:08 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Option Exercise	78.61	4,869	382,752	5,096	Jan 30 04:15 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Sale	84.58	4,869	411,820	227	Jan 30 04:15 PM
Tuite Tyler	Officer	Jan 28 '25	Proposed Sale	84.58	4,869	411,809		Jan 28 05:11 PM
Mayor-Mora Enrique N	EVP & CFO	Jan 15 '25	Option Exercise	63.04	5,000	315,200	25,260	Jan 17 04:41 PM
Mayor-Mora Enrique N	EVP & CFO	Jan 15 '25	Sale	81.43	5,000	407,150	20,260	Jan 17 04:41 PM
Livesay Jill A	VP, Controller & PAO	Jan 15 '25	Option Exercise	63.04	13,009	820,087	22,457	Jan 17 04:41 PM
Livesay Jill A	VP, Controller & PAO	Jan 15 '25	Sale	81.00	13,009	1,053,729	9,448	Jan 17 04:41 PM
Mayor-Mora Enrique N	Officer	Jan 15 '25	Proposed Sale	81.43	5,000	407,133		Jan 15 03:15 PM
Shamim Mohammad	EVP and CITO	Jan 08 '25	Option Exercise	63.04	12,845	809,749	24,583	Jan 10 04:42 PM
Shamim Mohammad	EVP and CITO	Jan 08 '25	Sale	81.94	12,845	1,052,519	11,738	Jan 10 04:42 PM
Shamim Mohammad	Officer	Jan 08 '25	Proposed Sale	81.94	12,845	1,052,472		Jan 08 04:37 PM
Lyski James	EVP, Chief Growth & Strat Off	Jan 02 '25	Option Exercise	63.04	57,986	3,655,437	80,789	Jan 03 04:13 PM
Lyski James	EVP, Chief Growth & Strat Off	Jan 02 '25	Sale	81.35	57,986	4,717,161	22,803	Jan 03 04:13 PM
Lyski James	Officer	Jan 02 '25	Proposed Sale	81.35	57,986	4,717,412		Jan 02 05:23 PM
Daniels Jon G	SVP, CAF	Dec 26 '24	Option Exercise	63.04	10,000	630,400	10,995	Dec 27 04:13 PM
Daniels Jon G	SVP, CAF	Dec 26 '24	Sale	85.30	10,000	853,000	995	Dec 27 04:13 PM
Daniels Jon G	SVP, CAF	Dec 24 '24	Option Exercise	63.04	30,245	1,906,645	31,240	Dec 26 04:15 PM
Daniels Jon G	SVP, CAF	Dec 24 '24	Sale	84.34	30,245	2,550,863	995	Dec 26 04:15 PM
Daniels Jon G	Officer	Dec 26 '24	Proposed Sale	85.30	10,000	853,039		Dec 26 04:07 PM
Daniels Jon G	Officer	Dec 24 '24	Proposed Sale	85.00	15,000	1,275,000		Dec 26 12:22 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your FINVIZ experience